📰 Functional Characterization News
Functional Characterization News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Functional Characterization. Real-time updates on events, politics, business and more.
December 15, 2023
Centenary students dominated the undergraduate poster competition at the 2023 Biomedical Research and Industry Day (BRAID) held at Louisiana State University-Shreveport in early November.
November 20, 2023
Studies suggest that IGF-1 DES peptide may induce hypertrophy and hyperplasia in various cell types.
June 25, 2023
The two most common skin disorders are hyperpigmentation (skin darkening) and hypopigmentation (skin lightening. The quantity and activity of melanocytes is the major determinant of these disorders.
May 30, 2023
EDEN PRAIRIE, Minn., May 30, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for...
August 10, 2022
The Sarcoma Foundation of America (SFA), an organization dedicated to increasing research and awareness for sarcoma, today announced that it has awarded close
December 7, 2021
/PRNewswire/ -- In 2019, more than $1.8 billion was spent on collagen supplements.1 As the market grows, some pet owners are naturally wondering if their...
December 7, 2021
/PRNewswire/ -- In 2019, more than $1.8 billion was spent on collagen supplements.1 As the market grows, some pet owners are naturally wondering if their...
October 21, 2021
This article considers the use of X-ray spectroscopy and synchrotron radiation to characterize the structure of halide perovskites.
May 7, 2021
News No Comments The University of Arkansas at Little Rock has selected the winners of the 2021 Student Research and Creative Works Expo. The annual event features the latest innovative research, service or professional work, and creative projects by the student researchers at UA Little Rock. The expo also featured presentations by the 2021 winners of the Signature Experience Awards, which provides students with grants to fund a signature experience, including a research project, creative ac...
April 10, 2021
Share: BELTSVILLE, Md., April 10, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (NASDAQ:NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today presented preclinical and investigational new drug (IND)-enabling data for NC762 at the American Association for Cancer Research (AACR) Annual Meeting 2021. NC762 is a humanized monoclonal antibody specific for B7-H4 and is being ...